The Speedboat RS2 device, developed by Creo Medical Ltd, is an advanced bipolar electrosurgical tool designed for minimally invasive endoscopic procedures like Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM). It features a 4.
The Speedboat RS2 device, developed by Creo Medical Ltd, is an advanced bipolar electrosurgical tool designed for minimally invasive endoscopic procedures like Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM). It features a 4.2-mm distal cutting section, proximal insulated areas, an integrated injection needle, and utilizes bipolar radiofrequency for cutting and microwave energy for coagulation. These features ensure precise tissue dissection, effective hemostasis, and minimal thermal damage.
The device is ideal for en bloc resection of gastrointestinal lesions, submucosal tumor excision, and treating esophageal motility disorders. Its integrated cutting, coagulation, and injection functionalities streamline workflows, reduce procedural time, and enhance safety. Clinical studies demonstrate its efficacy in reducing bleeding risks, lowering adverse events, and improving recovery outcomes compared to traditional monopolar tools. The Speedboat RS2 is versatile, user-friendly, and particularly effective for lesions in anatomically challenging locations.
Introduction: Acute cholecystitis in patients with malignant biliary obstruction can be difficult to manage, particularly when surgery is not feasible. Endoscopic transpapillary gallbladder drainage (ETGBD) is an attractive minimally invasive option, but selective cannulation of...
Introduction: Early detection of esophageal squamous cell carcinoma (ESCC) is critical for curative endoscopic treatment. However, subtle lesions are often missed during routine endoscopy. This meta-analysis evaluated whether deep learning (AI)-based endoscopic systems can improve...
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.